WNT5A and glioblastoma: Furthermore, an investigation of WNT5A expression was conducted using TIMER, revealing an upregulation of WNT5A in[MAIA1] nine cancer types, including colon adenocarcinoma (COAD) (num(T) = 457; num(N) = 41), GBM (num(T) = 153; num(N) = 5), head and neck squamous cell carcinoma (HNSC) (num(T) = 520; num(N) = 44), KIRP (num(T) = 290; num(N) = 32), liver hepatocellular carcinoma (LIHC) (num(T) = 371; num(N) = 50), LUSC (num(T) = 501; num(N) = 51), READ (num(T) = 166; num(N) = 10), STAD (num(T) = 412; num(N) = 35), thyroid carcinoma (THCA) (num(T) = 501; num(N) = 59).